CLIA Lab Director and Consulting Services Compared

A firm's word that its directors are “qualified” is not what a surveyor reads. CMS's director brochure tells directors to confirm qualifications, training and competency records for all personnel, and that includes the director's own file. Run these steps on any candidate, whoever supplies them.

1. Name your highest complexity. One high complexity test puts the whole director role under § 493.1443, which has no master's or bachelor's path.
2. Ask which paragraph, in writing. The candidate should name the exact path, such as “§ 493.1405(b)(2)”. A firm that cannot name it has not checked.
3. Collect the evidence for that path. A medical license in your state for the MD, DO and DPM paths; the pathology board certificate for (b)(1); a current certificate from an HHS-approved board for the doctoral path (the rule says “certified and continue to be certified”); the diploma or transcript for degree paths; letters or records showing the years spent directing or supervising nonwaived testing (high complexity testing for § 493.1443); and CE certificates adding up to at least 20 hours on the director's duties.
4. Check the state. Paragraph (a) of both sections requires a current state director license where the state issues one. Your CLIA state agency can tell you whether yours does.
5. Test a grandfather claim. It holds only for someone qualified and serving as director of that complexity in a CLIA-certified lab on December 28, 2024, and continuously since. Ask for the CLIA number and the dates.
6. Count their labs. Ask for the CLIA numbers of every nonwaived lab the person directs today, yours included. The limit is five.
7. File the change. CMS tells labs to notify the State Agency or accreditor within 30 days of a change in laboratory director.

Short on CE hours? CMS points directors to CDC's free Laboratory Director University courses, which cover some of the duties; the CMS director page links them.

None of the firm pages we read shows a sample agreement, so the terms are yours to write. The director stays responsible for everything the rule assigns, so the agreement should make each duty visible on paper. These are the clauses a part-time arrangement most often leaves vague.

• Visit dates and visit evidence. At least two on-site visits a year, at least 4 months apart, each leaving a signed record of what the director reviewed, as § 493.1407(c)(2) asks. A visit with no evidence of director work is a visit a surveyor cannot see.
• Reach between visits. How the lab reaches the director by phone or electronically, and how fast an answer comes when QC fails on a Saturday.
• Who does what, by name. Which duties go to a technical consultant or clinical consultant, who that person is, and the paragraph they qualify under. CMS says delegation must be in writing, and the director remains responsible.
• Review frequency. CMS notes that the regulations do not set how often the director reviews QC, PT and procedures: your SOP does. Put the same frequency in the agreement so the two match.
• PT ownership. Who enrolls the lab, who reviews each PT report and who signs the corrective action when an event is unsatisfactory. Our CAP vs API proficiency testing comparison covers the programs themselves.
• The lab count. A promise to tell you before taking on a lab that would exceed five.
• Notice to leave. Enough notice that you can find a successor and report the change within 30 days.

Competency sign-offs are where delegated duties most often go unrecorded (see what the competency rules ask); the competency assessment software comparison shows the tools that track them, and the inspection-readiness software comparison covers the ones that keep personnel files ready for a survey. On paper, our inspection checklist lists the records a surveyor pulls.